Whereas much of the current attention surrounding GLP-1 RAs, or glucagon-like peptide-1 receptor agonists, has been focused on their unexpected and potent effect on weight loss, one important aspect of this class of drugs should not be overlooked: GLP-1 RAs have been shown to reduce the risk of heart attack, stroke, and other major adverse cardiovascular events (MACE) in patients with type 2 diabetes who have or are at high risk for atherosclerosis
Focusing on collagen support, barrier function, and hydration will improve how the skin looks and feels
A new study by Zepbounds maker, Eli Lilly, examined data from nearly 5,000 people with obesity and obesity-related conditions in four different studies and found that the drugs weight-loss effects were stronger than those of a placebo
Many consumers also want body care products that help the skin look smoother, brighter, and more even
For them, the weight loss and improved health that came with semaglutide had a good effect on their sexual activity
Super responders lose weight quickly, while non-responders do not see treatment benefits